These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 8711496)

  • 21. Ifosfamide plus N-acetylcysteine in the treatment of small cell and non-small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial.
    Loehrer PJ; Birch R; Kramer BS; Greco FA; Einhorn LH
    Cancer Treat Rep; 1986 Jul; 70(7):919-20. PubMed ID: 3013402
    [No Abstract]   [Full Text] [Related]  

  • 22. Ifosfamide vs cyclophosphamide in cancer therapy.
    Weiss RB
    Oncology (Williston Park); 1991 May; 5(5):67-76; discussion 76-82, 84-6. PubMed ID: 1653004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An important new drug and regimen for non-small-cell lung Ca.
    Oncology (Williston Park); 1990 Oct; 4(10):21. PubMed ID: 1963314
    [No Abstract]   [Full Text] [Related]  

  • 24. Big question, small answer.
    Mok TS; Crowley J
    J Thorac Oncol; 2008 Feb; 3(2):105-6. PubMed ID: 18303427
    [No Abstract]   [Full Text] [Related]  

  • 25. Combined treatment with thymosin-alpha1 and low-dose interferon-alpha after ifosfamide in non-small cell lung cancer: a phase-II controlled trial.
    Salvati F; Rasi G; Portalone L; Antilli A; Garaci E
    Anticancer Res; 1996; 16(2):1001-4. PubMed ID: 8687090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study of high dose ifosfamide plus mesna in inoperable non small cell lung carcinoma.
    Pastran Z; le Chevalier T; Baldeyrou P; Spielmann M; Arriagada R; Droz JP; Rouesse J
    Eur J Cancer Clin Oncol; 1988 Jun; 24(6):1073-4. PubMed ID: 2842161
    [No Abstract]   [Full Text] [Related]  

  • 27. Response of dermatomyositis co-existing with non-small cell lung cancer to chemotherapy.
    Tsang KW; Lam WK; Ip M
    Respir Med; 1998 May; 92(5):788-90. PubMed ID: 9713644
    [No Abstract]   [Full Text] [Related]  

  • 28. Ifosfamide in advanced/disseminated breast cancer.
    Sorio R; Lombardi D; Spazzapan S; La Mura N; Tabaro G; Veronesi A
    Oncology; 2003; 65 Suppl 2():55-8. PubMed ID: 14586149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneous erections in a patient with erectile dysfunction after palliative chemotherapy for non-small cell lung cancer.
    Hejna M; Fiebiger WC; Reiter WJ; Raderer M
    Urol Int; 2001; 67(2):163-4. PubMed ID: 11490213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined chemo- and radiosensitivity testing with ifosfamide and ACNU in human lung cancer cell lines.
    Wolf M; Maasberg M; Pfab R; Havemann K
    J Cancer Res Clin Oncol; 1991; 117 Suppl 4():S187-92. PubMed ID: 1665491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient preference for extended palliative chemotherapy for non-small cell lung cancer.
    Hickish TF; Smith IE; Middleton G; Nicolson M
    Lancet; 1995 Apr; 345(8953):857-8. PubMed ID: 7534859
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of refractory malignant neoplasms with ifosfamide as single agent and in combination chemotherapy.
    Retsas S
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():151-7. PubMed ID: 6627241
    [No Abstract]   [Full Text] [Related]  

  • 33. Phase II trials of idarubicin, a new anthracycline.
    Rosso R; Ardizzoni A; Conte P; Fusco V; Gulisano M; Lionetto R; Pronzato P; Repetto L
    Chemioterapia; 1987 Jun; 6(2 Suppl):694. PubMed ID: 2855618
    [No Abstract]   [Full Text] [Related]  

  • 34. Feasibility trial of a combination of vinorelbine, ifosfamide, fluorouracil and folinic acid (VIF regimen) in advanced urothelial cancer.
    Mahjoubi M; Kattan J; Droz JP; Philippot I; Pautier P; Boutan-Laroze A; Azab M; Theodore C
    Eur J Cancer; 1993; 29A(2):285-6. PubMed ID: 8422298
    [No Abstract]   [Full Text] [Related]  

  • 35. Beau's lines.
    Chang CC; Wu CC
    QJM; 2013 Apr; 106(4):383. PubMed ID: 22408154
    [No Abstract]   [Full Text] [Related]  

  • 36. Ifosfamide-induced psychosis.
    Hernández R; Juan O; Alberola V
    Acta Oncol; 2004; 43(1):119-20. PubMed ID: 15068332
    [No Abstract]   [Full Text] [Related]  

  • 37. Ifosfamide as single-agent chemotherapy in inoperable non-small-cell lung cancer.
    Peake MD; Parker D
    Lancet; 1985 Aug; 2(8453):496-7. PubMed ID: 2863510
    [No Abstract]   [Full Text] [Related]  

  • 38. Rationale for chemotherapy for patients with advanced non-small-cell lung cancer.
    Greco FA
    Semin Oncol; 1986 Sep; 13(3 Suppl 3):92-6. PubMed ID: 2429369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New drug found active against lung cancers.
    Hospitals; 1982 Jun; 56(12):38. PubMed ID: 7042515
    [No Abstract]   [Full Text] [Related]  

  • 40. Phase I study of paclitaxel with standard dose ifosfamide in children with refractory solid tumors: a Pediatric Oncology Group study (POG 9376).
    Geller JI; Wall D; Perentesis J; Blaney SM; Bernstein M;
    Pediatr Blood Cancer; 2009 Mar; 52(3):346-50. PubMed ID: 18989889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.